Steve Yoo

Associate, Public Equity

Steve joined Sofinnova as an Associate in 2017. He focuses on public investments in global therapeutics companies. He has more than a decade of sellside and buyside experience following therapeutics companies. Steve will be working with Eric in managing Sofinnova’s public equities portfolio.

Before joining Sofinnova, Steve covered therapeutics companies at Surveyor Capital, a global multi-strategy hedge fund associated with Citadel LLC. Prior to this he was a senior manager of finance at Amgen, a global biotech company where he conducted Aranesp sales forecasts. Additionally, he worked as a sellside biotech analyst/associate at Leerink Partners, UBS and Sanford C. Bernstein.

Steve received his Masters of Business and Science from Keck Graduate Institute and his BS from MIT.

Assistant: Josie Kastelic


(650) 681-8487